Presentation and Analysis of the EFPIA Questionnaire 06/08 on the - PowerPoint PPT Presentation

Sep 24, 2023 •278 likes •574 views

Presentation and Analysis of the EFPIA Questionnaire 06/08 on the Centralised Procedure New Applications

Presentation and Analysis of the EFPIA Questionnaire 06/08 on the Centralised Procedure New Applications ��
Responses ��
Scientific Advice (questions 1 to 8) � ��
Accelerated Assessment (questions 9 – 12) � 16 requested accelerated assessment 25% [05/06 = 33%] � 6 granted accelerated assessment [05/06 = 5%] � 2 approved under accelerated assessment (3%) [05/06 = 5%] (4 converted to normal timetable) � US/FDA “priority review” granted to 16 of the cohort Comments: (free text) � No justification for refusal � Company “discouraged” to apply x 3
Conditional Approval/Exceptional Circumstances (questions 13-14) � 6/64 approved “on condition” � Only 2 applied for conditional approval � 3/64 approved “under exceptional circumstances” – only 2 applied
Validation Q 16 � No major issues encountered during validation for most applications � Helpful EMEA guidance during validation 06/08 scale 1-10 05/06 7.1 7.8
Initial Assessment Report (Q17/18) Rapporteur Q17 Co-rapporteur Q18
Initial Assessment Reports Q17 ��
Initial Assessment Reports Q18 ��
��
��
��

Recommend

EMA EFPIA workshop EMA EFPIA workshop Break- -out session no. 4 out session no. 4 Break

EMA EFPIA workshop EMA EFPIA workshop Break- -out session no. 4 out session no. 4 Break Longitudinal model-based test as primary analysis in phase III B. Bieth*, D. Renard*, I. Demin*, B. Hamrn*, G. Heimann*, Sigrid Balser** *

402 views • 15 slides

SIG ECI Questionnaire for ECI Questionnaire Questionnaire for Early Career Investigators ready

COST ACTION CA15137 MC meeting, Podgorica, 7 - 8 March 2019 SIG ECI Questionnaire for ECI Questionnaire Questionnaire for Early Career Investigators ready Draws from interviews of SIG ECI Stphani e and Karolina: first draft

721 views • 6 slides

Ski touring final analysis TEAM 13 Methodology: 1. Create a questionnaire 2. Collect data

Ski touring final analysis TEAM 13 Methodology: 1. Create a questionnaire 2. Collect data through questionnaire 3. Build up a plan about the analysis of the collected data 4. Analyzing the data: Cross tabulation Chi-square independence

355 views • 18 slides

Eardisland Feasibility Study Claire Storer Principal Engineer 1 1. Questionnaire Analysis 2.

10/01/2015 Eardisland Feasibility Study Claire Storer Principal Engineer 1 1. Questionnaire Analysis 2. Flood Data Review 3. Potential Alleviation Options 2 1 10/01/2015 Questionnaire 73 responses 3 areas: Flood History

406 views • 11 slides

Conceptual / Background Questionnaire (Students Questionnaire) CAMBODIA OVERVIEWS Country

10 13 September, 2018, Penang, Malaysia Capacity development workshop Conceptualization, Measurement and Use of Contextual Data Knowledge and Experience Sharing by Cambodia Conceptual / Background Questionnaire (Students Questionnaire)

226 views • 18 slides

EFPIA POSITION PAPER EFPIA POSITION PAPER THE EFPIA SURROGATE THE EFPIA SURROGATE ENDPOINT

EFPIA POSITION PAPER EFPIA POSITION PAPER THE EFPIA SURROGATE THE EFPIA SURROGATE ENDPOINT INITIATIVE ENDPOINT INITIATIVE EMEA/EFPIA Workshop on Biomarkers EMEA/EFPIA Workshop on Biomarkers London 15 December 2006 15 December 2006

586 views • 19 slides

Questionnaire December 20914 and Presentation To Residents January 2015 WE FACE A ONCE IN A

Village Questionnaire December 2014 Avon Dassett Community Benefit Society Limited Questionnaire December 20914 and Presentation To Residents January 2015 WE FACE A ONCE IN A LIFETIME OPPORTUNITY. Not only to save our pub, but to make it the

503 views • 37 slides

Grounded in Public Input and Data Analysis 1,182 responses to Questionnaire Community

Grounded in Public Input and Data Analysis 1,182 responses to Questionnaire Community Remarks and Email Comments 51 Interviews + 4 Day On-site Charrette Vision The downtown is the communitys center serving residents daily

570 views • 30 slides

Perform ance indicator questionnaire analysis 2 0 1 0 An agency of the European Union

Perform ance indicator questionnaire analysis 2 0 1 0 An agency of the European Union Questionnaires sent to 132 patients/ consumers 71 Responses received (54% ) (100% from PCWP members) Sent to every patient/ consumer who has

862 views • 38 slides

EMA EFPIA workshop EMA EFPIA workshop Breakout Session 3 Breakout Session 3 Evidence Synthesis

EMA EFPIA workshop EMA EFPIA workshop Breakout Session 3 Breakout Session 3 Evidence Synthesis in Drug Development for Special Populations, Ethnic Groups and Rare Diseases Oscar Della Pasqua GlaxoSmithKline LEADING STATEMENTS LEADING

465 views • 11 slides

EMA EFPIA workshop EMA EFPIA workshop EMA EFPIA workshop EMA EFPIA workshop Break Break- -out

EMA EFPIA workshop EMA EFPIA workshop EMA EFPIA workshop EMA EFPIA workshop Break Break- -out session no. 2 out session no. 2 Case Study Title: Case Study Title: M&S for dose adjustment in M&S for dose adjustment in renally

363 views • 25 slides

Local Plan Review - Updating Gravesham's Priorities for the next decade Questionnaire analysis

Local Plan Review - Updating Gravesham's Priorities for the next decade Questionnaire analysis only of 3612 Completed Responses Process and Timetable Infrastructure Evidence Base Requirements National, Regional Legislation, Appraisals e.g.

319 views • 19 slides

EMA EFPIA workshop EMA EFPIA workshop Breakout Session 2 Breakout Session 2 Assessing the

EMA EFPIA workshop EMA EFPIA workshop Breakout Session 2 Breakout Session 2 Assessing the Probability of Drug-Induced QTc-Interval Prolongation During Early Clinical Drug Development Oscar Della Pasqua GSK Background Background Drugs that

511 views • 19 slides

EMA EFPIA workshop EMA EFPIA workshop Break- -out session no. out session no. 2 2 Break

EMA EFPIA workshop EMA EFPIA workshop Break- -out session no. out session no. 2 2 Break Case Study Title: Design of a model based Case Study Title: dose-finding study in diabetes Marie Sandstrm, Global Director Clinical Pharmacometrics,

605 views • 14 slides

Status of implementing International standard at national level in ASEAN Countries - analysis

Status of implementing International standard at national level in ASEAN Countries - analysis result of questionnaire : section 1 Ramesh V Bhat M 11, Kakateeyanagar, Habshiguda, Hyderabad 500007, India rameshvbhat@yahoo.com Why questionnaire

715 views • 22 slides

OCCUPATIONAL WAGES SURVEY FOR TRINIDAD AND TOBAGO INSTRUCTION SHEET Questionnaire Questionnaire

OCCUPATIONAL WAGES SURVEY FOR TRINIDAD AND TOBAGO INSTRUCTION SHEET Questionnaire Questionnaire I NSTRUCTION AND E XPLANATIONS Section Item B 12. The contact person should be someone who has either filled out the return, supervised someone

606 views • 4 slides

KRSS ENGAGEMENT QUESTIONNAIRE PRESENTATION M A R C H 2 0 - A P R I L 1 7 , 2 0 2 0 A

S C H O O L D I S T R I C T N O . 5 7 - P R I N C E G E O R G E KRSS ENGAGEMENT QUESTIONNAIRE PRESENTATION M A R C H 2 0 - A P R I L 1 7 , 2 0 2 0 A SPECIAL THANK YOU To our Engagement Process Working Group who have spent hours of

136 views • 11 slides

and the Job Analysis Questionnaire Michele Colvard June 13, 2017 2 What Is Total Rewards?

1 Total Rewards and the Job Analysis Questionnaire Michele Colvard June 13, 2017 2 What Is Total Rewards? What does the package encompass? 3 Why Now? The organizational case for Total Rewards at Pitt Last study of its kind conducted

656 views • 11 slides

Report: Analysis of the RDA Organisational Member (mapping) questionnaire, 2015 2 nd December

Report: Analysis of the RDA Organisational Member (mapping) questionnaire, 2015 2 nd December 2015 @ OAB Call RDA Organisational & 2 Affiliated Members Organisation & Affiliate 3 Members Organisations & initiatives seen as

470 views • 19 slides

EMEA EFPIA Workshop 19Dec08 Integrating PGx Early into Drug Development: PK as a working

EMEA EFPIA Workshop 19Dec08 Integrating PGx Early into Drug Development: PK as a working example 1 EMEA-EFPIA Workshop on PGx 2008 - CASE 3 EMEA/EFPIA PGx in PK Workshop Case 3: PGx Data Submission to Biomarker Scientific Advice Task: What

569 views • 25 slides

The 2007 trends: EMEA analysis EMEA analysis The 2007 trends: Francesco Pignatti, MD Safety and

EMEA- -EFPIA INFO DAY EFPIA INFO DAY EMEA 5 February 2007 5 February 2007 Analysis of Performance Indicators for Analysis of Performance Indicators for Initial Applications/Full Applications Initial Applications/Full Applications The 2007

381 views • 22 slides

Implementation of the EFPIA New R&D and Regulatory Pathways Strategy Status 05 June 2014

Implementation of the EFPIA New R&D and Regulatory Pathways Strategy Status 05 June 2014 EFPIA Annual meetings, Lyon 1 Objectives of session Aligned understanding on The concept of Medicines Adaptive Pathways to Patients

861 views • 58 slides

Efpia survey on impact of the paediatric regulation on marketing authorization holders (Jan 2007

Efpia survey on impact of the paediatric regulation on marketing authorization holders (Jan 2007 Jun 2010) Judith Creba (Novartis Pharma) Craig Johnson (Eli Lilly) Angelika Joos (Merck Sharp & Dome) 23 May 2011 EFPIA/EMA Infoday - 23

1.46k views • 78 slides

Comments and proposals on the results of the EFPIA survey Paolo Tomasi MD PhD Head of

Comments and proposals on the results of the EFPIA survey Paolo Tomasi MD PhD Head of Paediatric Medicines, EMA An agency of the European Union General comments First 360 analysis of impact of Paediatric Regulation Very detailed

794 views • 38 slides